RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 154 filers reported holding RA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 7.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,216,000 | -16.8% | 93,705 | +5.8% | 0.02% | -15.0% |
| Q2 2019 | $2,663,000 | +157.3% | 88,545 | +54.7% | 0.02% | +185.7% |
| Q3 2018 | $1,035,000 | +122.1% | 57,230 | +22.1% | 0.01% | +133.3% |
| Q2 2018 | $466,000 | +110.9% | 46,853 | +12.6% | 0.00% | +50.0% |
| Q1 2018 | $221,000 | +3.8% | 41,612 | +66.0% | 0.00% | +100.0% |
| Q4 2017 | $213,000 | -34.5% | 25,073 | +12.6% | 0.00% | -50.0% |
| Q3 2017 | $325,000 | -14.9% | 22,267 | +9.3% | 0.00% | -33.3% |
| Q2 2017 | $382,000 | – | 20,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|